Fungal infections, particularly in immunocompromised individuals, are responsible for nearly four million deaths annually—however, current treatments are limited and are frequently ineffective. Now, ...

Mineralys’ therapy at the 50mg dosage met its primary endpoint by demonstrating a 15.4 point reduction in SBP versus a 7.9 point reduction for placebo at week 12 (p=0.001). In both trials ...